{"id":244553,"date":"2012-11-02T19:46:21","date_gmt":"2012-11-02T19:46:21","guid":{"rendered":"http:\/\/www.eugenesis.com\/bayer-to-acquire-schiff-nutrition-international-for-us-1-2-billion\/"},"modified":"2012-11-02T19:46:21","modified_gmt":"2012-11-02T19:46:21","slug":"bayer-to-acquire-schiff-nutrition-international-for-us-1-2-billion","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/nutrition\/bayer-to-acquire-schiff-nutrition-international-for-us-1-2-billion.php","title":{"rendered":"Bayer to acquire Schiff Nutrition International for US$ 1.2 billion"},"content":{"rendered":"<p><p>    LEVERKUSEN, Germany, MORRISTOWN, N.J., SALT LAKE CITY, Oct. 30,    2012 \/PRNewswire\/ --Bayer HealthCare LLC has signed a merger    agreement to acquire Schiff Nutrition International, Inc.    (SHF),    a leading company offering vitamins and nutritional supplements    in the United States and other countries. Schiff's product    portfolio includes core brands MegaRed, Move Free and    Airborne, among others. The transaction values Schiff at    approx. US$1.2 billion (approx. 920 million) representing    US$34 per share in cash. Closing is subject to customary    closing conditions and is expected by year end 2012.  <\/p>\n<p>    \"Bayer is committed to augment its organic growth with    strategic bolt-on acquisitions. This transaction represents an    excellent strategic fit for our HealthCare business,\" said    Dr.Marijn Dekkers, CEO of Bayer AG. \"The Schiff business    significantly enhances our presence and position in the United    States, which accounts for more over-the-counter and    nutritional products sales than any other country in the    world.\"  <\/p>\n<p>    \"We will utilize our extensive marketing, sales and    distribution expertise to further develop the strong brands we    are acquiring,\" said Dr. Jorg Reinhardt, CEO of Bayer    HealthCare. \"We will also look to leverage Schiff's new    technology platforms with innovation potential for other    Bayer-owned brands and markets globally.\"  <\/p>\n<p>    Tarang P. Amin, President and CEO of Schiff, said, \"Schiff has    a 75 year heritage of providing consumers with quality    nutritional products. We are focused on building premium brands    and leading innovation. We believe Bayer is well positioned to    take our leading brands to the next level.\"  <\/p>\n<p>    Schiff generated net sales of US$259 million (approx. 200    million) for its fiscal year ended May 31, 2012. On September    18, 2012, Schiff publicly announced that net sales for fiscal    year 2013 were projected to grow between 43 and 46 percent.    Expected sales growth includes contributions from new products    and brand building as well as Airborne, which was acquired by    Schiff on March 30, 2012.   <\/p>\n<p>    The company employs approximately 400 people with its    headquarters and manufacturing site based in Salt Lake City,    Utah, as well as offices in Emeryville, California. The Schiff    portfolio includes strong brands in three of the largest health    supplement segments including Joint Care (Move Free),    Cardiovascular Health  <\/p>\n<p>    (MegaRed) and Immune Support (Airborne), among others. These    products complement Bayer's existing OTC portfolio and will    allow it to provide consumers with a broad range of options in    these key segments.  <\/p>\n<p>    Bayer: Science For A Better Life  <\/p>\n<p>    Bayer is a global enterprise with core competencies in the    fields of health care, agriculture and high-tech materials. As    an inventor company, it sets trends in research-intensive    areas. Bayer's products and services are designed to benefit    people and improve the quality of life. At the same time, the    Group aims to create value through innovation, growth and high    earning power. Bayer is committed to the principles of    sustainable development and acts as a socially and ethically    responsible corporate citizen. In fiscal 2011, the Group    employed about 112,000 people and had sales of 36.5 billion.    Capital expenditures amounted to 1.7 billion, R&D expenses    to 2.9 billion. For more information, go to <a href=\"http:\/\/www.bayer.com\" rel=\"nofollow\">http:\/\/www.bayer.com<\/a>.  <\/p>\n<p>    About Bayer HealthCare  <\/p>\n<\/p>\n<p>Go here to read the rest:<br \/>\n<a target=\"_blank\" href=\"http:\/\/finance.yahoo.com\/news\/bayer-acquire-schiff-nutrition-international-053700174.html;_ylt=A2KJ3CXmIpRQZXcAHeL_wgt.\" title=\"Bayer to acquire Schiff Nutrition International for US$ 1.2 billion\">Bayer to acquire Schiff Nutrition International for US$ 1.2 billion<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> LEVERKUSEN, Germany, MORRISTOWN, N.J., SALT LAKE CITY, Oct. 30, 2012 \/PRNewswire\/ --Bayer HealthCare LLC has signed a merger agreement to acquire Schiff Nutrition International, Inc. (SHF), a leading company offering vitamins and nutritional supplements in the United States and other countries.  <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/nutrition\/bayer-to-acquire-schiff-nutrition-international-for-us-1-2-billion.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":57,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[577479],"tags":[],"class_list":["post-244553","post","type-post","status-publish","format-standard","hentry","category-nutrition"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/244553"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/57"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=244553"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/244553\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=244553"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=244553"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=244553"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}